Harpoon (system of recovery of the mitralny valve)

2020: Start of use of a system of recovery of the mitralny valve without open heart operations

At the end of December, 2020 Edwards Lifesciences for the first time used the system of recovery of the mitralny valve without operations on open heart of Harpoon during clinical trials.

According to the press release, Harpoon represents the system of recovery of the mitralny valve which can be used using less invasive equipment, than open heart operation, for treatment of a heavy degenerative regurgitation of the mitralny valve. The Edwards company performed the first procedure for recovery of the valve in the Medical center of the University of Maryland in Baltimore.

Researchers from the Center of heart and vessels of the Maryland university developed the Harpoon system for recovery of the mitralny valve which is entered through a small section and do not demand cardiac arrest and use of the cardiopulmonary bypass.

Doctors of Edwards Lifesciences began to use the system of recovery of the mitralny valve without operations on open heart of Harpoon

Patients with a heavy degenerative regurgitation of the mitralny valve can note the expressed restrictions in everyday life, beginning from decrease in physical activity to more serious complications, - the head of department of cardiovascular surgery of Piedmont Healthcare doctor Vinod Thourani explained. - Using less invasive approaches, we can get rid of a part of traditional transactions on open heart and the related difficulties complicating recovery of the patient.

According to Edwards, about 360 patients who need operation on recovery of the mitralny valve because of a heavy degenerative regurgitation of the mitralny valve will enter the research Restore. The corporate vice president of Edwards Daveen Chopra noted that Restore will fill up the growing volume of proofs for benefit of the Harpoon system which is also estimated within post-marketing research of Ascend in Europe.^[1]

Notes